Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 5, 2008 - Issue 9
Submit an article Journal homepage
792
Views
64
CrossRef citations to date
0
Altmetric
Reviews

Drug delivery approaches to overcome bacterial resistance to β-lactam antibiotics

Sampath C Abeylath University of South Florida, Center for Molecular Diversity in Drug Design, Discovery, and Delivery, Department of Chemistry, CHE 205, 4202 East Fowler Avenue, Tampa, FL 33620, USA +1 813 974 7312; +1 813 974 1733; [email protected]
&
Edward Turos University of South Florida, Center for Molecular Diversity in Drug Design, Discovery, and Delivery, Department of Chemistry, CHE 205, 4202 East Fowler Avenue, Tampa, FL 33620, USA +1 813 974 7312; +1 813 974 1733; [email protected]
Pages 931-949 | Published online: 29 Aug 2008

Bibliography

  • Broccolo F, Cainelli G, Caltabiano G, et al. Design, synthesis, and biological evaluation of 4-alkyliden-β-lactams: new products with promising antibiotic activity against resistant bacteria. J Med Chem 2006;49:2804-11
  • Wilke MS, Lovering AL, Natalie CJ, Strynadka NCJ. β-lactam antibiotic resistance: a current structural perspective. Curr Opin Microbiol 2005;8:525-33
  • Dantzig AH. Oral absorption of β-lactams by intestinal peptide transport proteins. Adv Drug Deliv Rev 1997;23:63-76
  • Waxman DJ, Strominger JL. Sequence of active site peptides from the penicillin-sensitive D-alanine carboxypeptidase of Bacillus subtilis. J Biol Chem 1980;255:3964-76
  • Frere JM, Nguyen-Disteche M, Coyette J, Joris B. Interaction with the penicillin binding proteins. In: Page, MI, editor, The chemistry of β-lactams. Blackie Academic and Professional, NewYork; 1992. p. 148-97
  • Ghuysen JM, Charlier P, Coyette J, et al. Penicillin and beyond: evolution, protein fold, multimodular polypeptides, and multiprotein complexes. Microb Drug Resist 1996;2:163-75
  • Goffin C, Ghuysen JM. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol Mol Biol Rev 1998;62:1079-93
  • Kotra LP, Mobashery S. β-lactam antibiotics, β-lactamases and bacterial resistance. Bull Inst Pasteur 1998;96:139-50
  • Knowles JR. Penicillin resistance: the chemistry of β-lactamase inhibition. Acc Chem Res 1985;18:97-104
  • Therrien C, Levesque RC. Molecular basis of antibiotic resistance and β-lactamase inhibition by mechanism-based inactivators: perspectives and future directions. FEMS Microbiol Rev 2000;24:251-62
  • Chambers HF. Methicillin-resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997;10:781-91
  • Klevins RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71
  • Mukhopadhyay S, Chakrabarti P. Altered permeability and β-lactam resistance in a mutant of Mycobacterium smegmatis. Antimicrob Agents Chemother 1997;41:1721-4
  • Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001;47:247-50
  • Babic M, Hujer AM, Bonomo RA. What's new in antibiotic resistance? Focus on β-lactamases. Drug Res Updates 2006;9:142-56
  • Adam D. β-lactam/β-lactamase inhibitor combinations in empiric management of pediatric infections. J Int Med Res 2002;30(Suppl 1):10A-19A
  • Adam D. β-lactam antibiotics: their role in the management of infections in children. Pediatr Infect Dis J 1998;17:S4-S7
  • Moosdeen F. Impact of β-lactamases on the clinical use of β-lactam antibiotics. In: Viewpoints in medicine, countering resistance due to β-lactamases. Worthing: Cambridge Medical Publications; 1996. p. 6-11
  • Moosdeen F. The evolution of resistance to cephalosporins. Clin Infect Dis 1997;24:487-93
  • Livermore DM. Bacterial resistance to carbapenems. Adv Exp Med Biol 1995;390:25-47
  • Rolinson GN. Evolution of β-lactamase inhibitors. Rev Infect Dis 1991;13:S727-32
  • Brown AG, Corbett DF, Eglington AJ, Howarth. Structures of olivanic acid derivatives MM 4550 and MM 13902;two new, fused β-lactams isolated from Streptomyces olivaceus. J Chem Soc Chem Commun 1977;523-5
  • Reading C, Cole M. Clavulanic acid: a β-lactamase inhibiting β-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother 1977;11:852-857
  • Wildfeuer A, Rader K. Stability of β-lactamase inhibitors and β-lactam antibiotics in parenteral dosage forms and in body fluids and tissue homogenates: a comparative study of sulbactam, clavulanic acid, ampicillin and amoxicillin. Int J Antimicrob Agents 1996;6:S31
  • Grimm H. Comparative in vitro studies on the β-lactamase-inhibiting effect of clavulanic acid and sulbactam on ampicillin-resistant Enterobacteriaceae. Int J Antimicrob Agents 1996;6:S9
  • Lee N, Yuen KY, Kumana CR. Clinical role of β-lactam/β-lactamase inhibitor combinations. Drugs 2003;63:1511-24
  • Buynak JD. Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinations. Biochem Pharmacol 2006;71:930-40
  • Martinez JL, Vicente MF, Delgado-Iribarren A, et al. Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob Agents Chemother 1989;33:595
  • Wu PJ, Shannon K, Phillips I. Effect of hyperproduction of TEM-1 β-lactamase on in vitro susceptibility of Escherichiacoli to β-lactam antibiotics. Antimicrob Agents Chemother 1994;38:494-8
  • Wu PJ, Shannon K, Phillips I. Mechanisms of hyperproduction of TEM-1 β-lactamase by clinical isolates of Escherichia coli. J Antimicrob Chemother 1995;36:927-39
  • Reguera JA, Baquero F, Perez-Diaz JC, Martinez JL. Factors determining resistance to β-lactam combined with blactamase inhibitors in Escherichia coli. J Antimicrob Chemother 1991;27:569-75
  • Bonomo RA, Rice LB. Inhibitor resistant class A β-lactamases. Front Biosci 1999;4:34-41
  • Nicolas-Chanoine MH. Inhibitor-resistant β-lactamases. J Antimicrob Chemother 1997;40:1-3
  • Chaibi EB, Sirot D, Paul G, Labia R. Inhibitor-resistant TEM β-lactamases: phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother 1999;43:447-58
  • Yang Y, Rasumussen BA, Shlaes DM. Class A β-lactamases: enzyme-inhibitor interactions and resistance. Pharmacol Ther 1999;83:141-51
  • Yoshimura F, Nikaido H. Diffusion of β-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob Agents Chemother 1985;27:84-92
  • Hakimelahi GH, Shia K, Xue C, et al. Design, synthesis, and biological evaluation of a series of β-lactam-based prodrugs. Bioorg Med Chem 2002;10:3489-98
  • Kazmierczak A, Cordin X, Jduez JM, et al. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria. J Int Med Res 1990;18:D67-77
  • Livermore DM, Akova M, Wu PJ, Yang YJ. Clavulanate and β-lactamase induction. J Antimicrob Chemother 1989;24(Suppl B):23-33
  • Li Q, Lee JY, Castillo R, et al. NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against β-lactamase-producing strains. Antimicrob Agents Chemother 2002;46:1262-8
  • Stone GW, Zhang Q, Castillo R, et al. Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by β-lactamases. Antimicrob Agents Chemother 2004;48:477-83
  • Wang Y, Lambart P, Zhao L, Wang D. Synthesis and antibacterial activity of dual-action agents of a β-lactam antibiotic with cytotoxic agent mitozolomide or temozolomide. Eur J Med Chem 2002;37:323-32
  • Hakimelahi GH, Moosavi-Movahedi AK, Saboury AA, et al. Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems. Eur J Med Chem 2005;40:339-49
  • Carryn S, Chanteux H, Seral C, et al. Intracellular pharmacodynamics of antibiotics. Infect Dis Clin N Am 2003;17:615-34
  • Carryn S, Van Bambeke F, Mingoet-Leclercq MP, Tulkens PM. Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model. J Antimicrob Chemother 2003;51:1051-2
  • Lemaire S, Van Bambeke F, Mingoet-Leclercq MP, Tulkens PM. Activity of three β-lactams (entrapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus. J Antimicrob Chemother 2005;55:897-904
  • Lemaire S, Bambeke FV, Mingeot-Leclercq MP, et al. Carbapenems are active against intracellular MRSA [abstract A-1832]. 45th Intersci Conf Antimicrob Agents Chemother. American Society for Microbiology, Washington, DC; 2005
  • Lemaire S, Van Bambeke F, Mingoet-Leclercq MP, et al. Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin. Antimicrob Agents Chemother 2007;51:1627-32
  • Chanteux H, Mingoet-Leclercq MP, Sonoveaux E, et al. Intracellular accumulation and activity of ampicillin used as free drug and as its phthalimidomethyl or pivaloyloxymethyl ester (pivampicillin) against Listeria monocytogenes in J774 macrophages. J Antimicrob Chemother 2003;52:610-5
  • Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 2004;303:1818-1822
  • Soppimath KS, Aminabhavi TM, Kulkami AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1-20
  • Ravi Kumar MNV. Nano and microparticles as controlled drug delivery devices. J Pharm Pharm Sci 2000;3:234-58
  • Williams J, Lansdown R, Sweitzer R, et al. Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors. J Control Release 2003;91:167-72
  • Fernandez-Urrusuno R, Fattal E, Rodrigues JM, et al. Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. J Biomed Mater Res 1996;31:401-8
  • Lobenberg R, Kreuter J. Macrophage targeting of azidothymidine:a promising strategy for AIDS therapy. AIDS Res Hum Retroviruses 1996;12:1709-15
  • Reilly RM, Sandhu J, Alvarez-Diez TM, et al. Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions. Clin Pharmacokinet 1995;28:126-42
  • Chun L. Poly(L-glutamic acid)-anticancer drug conjugates. Adv Drug Deliv Rev 2002;54:695-713
  • Elizabeth R, Gillies J, Frechet MJ. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 2005;10:35-43
  • Huwyler J, Wu D, Paradridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA 1996;93:14164-9
  • Uekama K, Otagiri M. Cyclodextrins in drug carrier systems Crit Rev Ther Drug Carrier Syst 1987;3:1-40
  • Venier-Julienne MC, Benoit JP. Preparation, purification and morphology of polymeric nanoparticles as drug carriers. Pharm Acta Helv 1996;71:121-8
  • Risbud MV, Hardikar AA, Bhat SV, Bhode RR. pH-sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J Control Release 2000;68:23-30
  • Martens PJ, Bryant SJ, Anseth KS. Tailoring the degradation of hydrogels formed from multivinyl poly(ethylene glycol) and poly(vinyl alcohol) macromers for cartilage tissue engineering. Biomacromolecules 2003;4:283-92
  • Changez M, Koul V, Dinda AK. Efficacy of antibiotics-loaded interpenetrating network (IPNs) hydrogel based on poly(acrylic acid) and gelatin for treatment of experimental osteomyelitis: in vivo study. Biomaterials 2005;26:2095-104
  • Kreuter J. Nanoparticle-based drug delivery systems. J Control Release 1991;16:169-76
  • Couvreur P, Fattal E, Alphandary H, et al. Intracellular targeting of antibiotics by means of biodegradable nanoparticles. J Control Release 1992;19:259-67
  • Jani P, Halbert W, Langridge J, Florence AT. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol 1989;41:809-12
  • Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomed Nanotechnol Biol Med 2006;2:8-21
  • Kuo PL, Turro NJ, Tseng CH, et al. Photoinitiated polymerization of styrene in microemulsions. Macromolecules 1987;20:1216-21
  • Huguette PA, Andremont A, Couvreur P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents 2000;13:155-68
  • Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 1990;42:821-6
  • Jani P, Halbert GW, Langridge J, Florence AT. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol 1989;41:809-12
  • Cui Z, Mumper RJ. The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses. Eur J Pharm Biopharm 2003;55:11-8
  • Kreuter J, Speiser PP. New adjuvants on a poly(methyl methacrylate) base. Infect Immun 1976;13:204-10
  • Couvreur P, Kante B, Roland M, et al. Polycyano acrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J Pharm Pharmacol 1979;31:331-2
  • Vauthier C, Dubernet C, Fattal E, et al. Poly(alkyl cyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev 2003;55:519-48
  • Velaga SP, Ghaderi R, Carlfors J. Preparation and characterisation of hydrocortisone particles using a supercritical fluids extraction process. Int J Pharm 2002;231:155-66
  • Cavallaro GM, Fresta G, Giammona G, Villari PA. Entrapment of β-lactams antibiotics in polyethylcyanoacrylate nanoparticles: studies on the possible in vivo application of this colloidal delivery system. Int J Pharm 1994;111:31-41
  • Fattal E, Youssef M, Couvreur P, Andremont A. Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. Antimicrob Agents Chemother 1989;33:1540-3
  • Balland O, Pinto-Alphandary H, Viron A, et al. Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H)ampicillin-loaded nanoparticles J Antimicrob Chemother 1996;37:105-15
  • Fontana G, Pitarresi G, Tomarchio V, et al. Preparation, characterization and in vitro antimicrobial activity of ampicillin-loaded poly(ethyl cyanoacrylate) nanoparticles. Biomaterials 1998;19:1009-17
  • Fontana G, Licciardi M, Mansueto S, et al. Amoxicillin-loaded poly(ethyl cyanoacrylate) nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 2001;22:2857-65
  • Turos E, Reddy GSK, Greenhalgh K, et al. Penicillin-bound polyacrylate nanoparticles: restoring the activity of β-lactam antibiotics against MRSA. Bioorg Med Chem Lett 2007;17:3468-72
  • Diilen K, Weyenberg Vandervoort J, Ludwig A. The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. Eur J Pharm Biopharm 2004;58:539-49
  • Prior S, Gamazo C, Irache JM, et al. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Int J Pharm 2000;196:115-25
  • Santos-Magalhaes NS, Pontes A, Pereira VMW, Caetano MNP. Colloidal carriers for benzathine penicillin G: nanoemulsions and nanocapsules. Int J Pharm 2000;208:71-80
  • Taton AT, Mirkin CA, Letsinger RL. Scanometric DNA array detection with nanoparticle probes. Science 2000;289:1757-60
  • Prime KL, Whitesides GM. Self-assembled organic monolayers: model systems for studying adsorption of proteins at surfaces. Science 1991;252:1164-767
  • Diaz HVR, Batdorf KH, Fianchinin M, et al. Antimicrobial properties of highly fluorinated silver(I) tris(pyrazolyl)borates. J Inorg Biochem 2006;100:158-60
  • Balogh L, Swanson DR, Tomalia DA, et al. Dendrimer-silver complexes and nanocomposites as antimicrobial agents. Nano Lett 2001;1:18-21
  • Ramstedt M, Cheng N, Azzaroni O, et al. Synthesis and characterization of poly(3-sulfopropylmethacrylate) brushes for potential antibacterial applications. Langmuir 2007;23:3314-21
  • Kong H, Jang J. Antibacterial properties of novel poly(methyl methacrylate) nanofiber containing silver nanoparticles. Langmuir 2007;24:2051-6
  • Dibrov P, Dzioba J, Gosink KK, Hase CC. Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholerae. Antimicrob Agents Chemother 2002;46:2668-70
  • Panacek A, Kvitek L, Prucek R, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B 2006;110:16248-53
  • Li P, Li J, Wu C, et al. Synergic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles. Nanotechnology 2005;16:1912-7
  • De Souza A, Mehta D, Leavitt RW. Bactericidal activity of combinations of silver-water dispersion with 19 antibiotics against seven microbial strains. Curr Sci 2006;91:926-9
  • Gu H, Ho PL, Tong E, et al. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett 2003;3:1261-3
  • Tom RT, Suryanarayanan V, Reddy PG, et al. Ciprofloxacin-protected gold nanoparticles. Langmuir 2004;20:1909-14
  • Goodman CM, Mccusker CD, Yilmaz T, Rotello VM. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 2004;15:897-900
  • Chen JF, Ding HM, Wang JX, Shao L. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 2004;25:723-7
  • Yoshida T, Qin L, Linda AE, Masayori I. Transcription regulation of ompF and ompC by a single transcription factor, OmpR. J Biol Chem 2006;281:17114-23
  • Raja SB, Murali MR, Devaraj SN. Differential expression of ompC and ompF in multidrug-resistant Shigella dysenteriae and Shigella flexneri by aqueous extract of Aegle marmelos, altering its susceptibility toward β-lactam antibiotics. Diagn Micro Infect Dis 2008; In press
  • Davies TA, Page MG, Shang W, et al. Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Antimicrob Agents Chemother 2007;51:2621-4
  • Lodisea TP, Patela N, Renaud-Mutarta A, et al. Pharmacokinetic and pharmacodynamic profile of ceftobiprole. Diagn Microb Infect Dis 2008; In press
  • Turos E, Konaklieva MI, Ren Rxf, et al. N-Thiolated bicyclic and monocyclic β-lactams. Tetrahedron 2000;56:5571-8
  • Turos E, Konaklieva MI, Coates C, et al. N-Thiolated β-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus. Bioorg Med Chem Lett 2002;12:2229-31
  • Turos E, Long TE, Heldreth B, et al. N-Thiolated β-lactams: a new family of anti-Bacillus agents. Bioorg Med Chem Lett 2006;16:2084-90
  • Revell KD, Heldreth B, Long TE, et al. N-thiolated β-lactams: studies on the mode of action and identification of a primary cellular target in Staphylococcus aureus. Bioorg Med Chem 2007;15:2453-67
  • Turos E, Shim JY, Wang Y, et al. Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents. Bioorg Med Chem Lett 2007;17:53-6
  • Abeylath SC, Turos E, Dickey S, Lim DV. Glyconanobiotics: novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis. Bioorg Med Chem 2007;16:2412-8
  • Fleming A. Penicillin. Nobel lecture; 11 December 1945
  • Harbarth S, Samore MH. Antimicrobial resistance determinants and controls. Emerg Infect Dis 2005;11:794-801
  • Lewis K. Persister cells, dormancy, and infectious disease. Nat Rev Microbiol 2007;5:48-56

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.